HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    
FREE winning picks
Quote:
Login
Search:

Top Zacks Features
Free Membership
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
Zacks Trading Game
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Surprise Trader
Top 10 Stocks
Value Trader
Value Trader 2
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
  • Free  Four Zacks #1 Rank "Strong Buy" Stocks
  • Free  Timely Market Commentary
  • Free  Wealth Management Tips
  • Free  Profitable Strategy Screens
  • Free  Bull and Bear Stocks of the Day
Zacks FREE Registration
Receive Special Offers                  Privacy Policy
Close This Panel X

MDT: Medtronic Inc - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

MEDTRONIC INC (NYSE)
MDT 34.26 -0.45 (-1.30%) Vol.  5,998,910 16:16 ET

Day Low - High 33.84 - 34.91
52wk Low - High 24.06 - 56.97
Avg Volume 7,004,139
Industry MED PRODUCTS
Market Cap 38.11 B
Div - Yield 0.75 - 2.19
PE (forward) 10.93
PEG Ratio 1.03
Current Year Est. 3.13
EPS Last Year 2.92
Detailed Quote


Zacks Premium Research
Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
#1 Strong Buy 26.51%
#2 Buy 16.63%
#3 Hold 7.53%
#4 Sell 2.01%
#5 Strong Sell -0.07%
S&P 500 8.70%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations

Zacks Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

Rank in Industry

By clicking on the Rank in Industry link you will see best companies in the industry as judged by the Zacks Rank.

Zacks Rank Education - Learn more about the Zacks Rank
Zacks Premium - The only way to get access to the Zacks Rank and Rank in Industry

Zacks Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations



BROKERAGE RECOMMENDATIONS
Current ABR 1.86
ABR (Last Week) 1.86
# of Recs in ABR 21
Average Target Price 41.65
Industry Rank by ABR 43 out of 217
Rank in Industry 23 out of 69
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate MDT?
Buy
Sell
Find out what the Zacks Community
thinks of MDT at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart
 New: Zacks Trading Game



NEWS FOR MDT
Jul 03, 2009 00:37 FDA OKs LUCAS 2 Chest Compression System
Jun 30, 2009 07:10 Medtronic Steps Up Trials for Stroke
Jun 29, 2009 09:00 FDA Grants LUCAS(TM) 2 Chest Compression System 510(k) Clearance in the United States
Jun 27, 2009 07:10 ev3 Acquires Pipeline Device
Jun 26, 2009 23:47 Medtronic: More-Care Trial to Assess Remote Monitoring Impact on Heart Failure Patients and Healthcare Utilization
More News

ZACKS COMMENTARY FOR MDT
Jul 02, 2009 Zacks Blog: Searching for Best Treatment
Jul 01, 2009 Zacks Blog: Medtronic Keeps Growing
Jun 29, 2009 Zacks Blog: Medtronic Steps Up Trials for Stroke
Jun 26, 2009 Zacks Blog: ev3 Acquires Pipeline Device
Jun 19, 2009 Zacks Blog: MDT & Conflicts of Interest
More Commentaries

EARNINGS ESTIMATES
  This Quarter
07/2009
Next Quarter
10/2009
This Year
04/2010
Next Year
04/2011
Average Estimate 0.78 0.75 3.13 3.46
Number of Estimates 23 22 27 18
Low Estimates 0.73 0.72 3.03 3.36
High Estimate 0.82 0.78 3.26 3.55
Year Ago EPS 0.72 0.67 2.92 3.13
EPS Growth 8.03% 12.01% 7.32% 10.47%

More Estimates

COMPANY DESCRIPTION
Medtronic is the world's leading medical technology company, pioneering device-based therapies that restore health, extend life and alleviate pain. Primary products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, among others. Medtronic operates its business in one reportable segment, that of manufacturing and selling device-based medical therapies. The company does business in more than 120 countries. The company's product lines include cardiac rhythm management, neurological and spinal, vascular and cardiac surgery.

Full Company Report
FINANCIALS
EPS TTM 2.92
Sales 14599
Net Income 2291
Price/Earnings 11.73
Price/Book 2.98
Price/Cash Flow 9.63
Price/Sales 2.61


More Financials

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research